Risk factors for radiation pneumonitis after stereotactic radiation therapy for lung tumours: clinical usefulness of the planning target volume to total lung volume ratio

• Published in: British journal of radiology 2018-06, Vol.91 (1086), p.20170453-20170453
• Main Authors: Ueyama, Tomoko, Arimura, Takeshi, Takumi, Koji, Nakamura, Fumihiko, Higashi, Ryutaro, Ito, Soichiro, Fukukura, Yoshihiko, Umanodan, Tomokazu, Nakajo, Masanori, Koriyama, Chihaya, Yoshiura, Takashi
• Format: Article
• Language: English
• Subjects: Follow-Up Studies; Humans; Lung - anatomy & histology; Lung - pathology; Lung Neoplasms - pathology; Lung Neoplasms - radiotherapy; Organ Size; Radiation Pneumonitis - etiology; Radiosurgery - adverse effects; Radiotherapy Dosage; Retrospective Studies; Risk Factors; ROC Curve; Tumor Burden
• ISSN: 0007-1285; 1748-880X
• DOI: 10.1259/bjr.20170453

To identify risk factors for symptomatic radiation pneumonitis (RP) after stereotactic radiation therapy (SRT) for lung tumours. We retrospectively evaluated 68 lung tumours in 63 patients treated with SRT between 2011 and 2015. RP was graded according to the National Cancer Institute-Common Terminology Criteria for Adverse Events version 4.0. SRT was delivered at 7.0-12.0 Gy per each fraction, once daily, to a total of 48-64 Gy (median, 50 Gy). Univariate analysis was performed to assess patient- and treatment-related factors, including age, sex, smoking index (SI), pulmonary function, tumour location, serum Krebs von den Lungen-6 value (KL-6), dose-volume metrics (V5, V10, V20, V30, V40 and VS5), homogeneity index of the planning target volume (PTV), PTV dose, mean lung dose (MLD), contralateral MLD and V2, PTV volume, lung volume and the PTV/lung volume ratio (PTV/Lung). Performance of PTV/Lung in predicting symptomatic RP was also analysed using receiver operating characteristic (ROC) analysis. The median follow-up period was 21 months. 10 of 63 patients (15.9%) developed symptomatic RP after SRT. On univariate analysis, V10, V20, PTV volume and PTV/Lung were significantly associated with occurrence of RP  ≥Grade 2. ROC curves indicated that symptomatic RP could be predicted using PTV/Lung [area under curve (AUC): 0.88, confidence interval (CI: 0.78-0.95), cut-off value: 1.09, sensitivity: 90.0% and specificity: 72.4%]. PTV/Lung is a good predictor of symptomatic RP after SRT. Advances in knowledge: The cases with high PTV/Lung should be carefully monitored with caution for the occurrence of RP after SRT.